At the recent scientific meeting of the American Academy of Child and Adolescent Psychiatry, a study was released which documented that Strattera improved ADHD and Reading Disorder (dyslexia). I will summarize this study here, but if you want to read the full report, please visit here.
In this study, children aged 10-16 were treated with Strattera for their ADHD for 16 weeks. There were two main groups – children who had ADHD alone, compared to children who had ADHD plus a Reading Disorder (Dyslexia).
At the end of the study, there was approximately a 50% improvement in ADHD symptoms in both groups.
The interesting difference came when looking at improvement in reading scores. The ADHD and Reading Disorder group had a 2 year improvement in their reading scores, compared to a 17 month improvement in the ADHD group.
Although Strattera is not approved for the treatment of Reading Disorder/Dyslexia, these are encouraging results.